Fig. 3From: The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapyIL-1β expression and early response rates in different groups. (a) IL-1β mRNA in Group A and the control group was measured by means of qRT-PCR in PBMCs. (b) IL-1β in Group A and the control group was measured using ELISA in plasma. (c) Early virological response rates for Groups B, C, and DBack to article page